IRIS
AIMO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.207
AS - Asia 19.794
EU - Europa 16.681
SA - Sud America 4.483
AF - Africa 532
Continente sconosciuto - Info sul continente non disponibili 502
OC - Oceania 50
Totale 75.249
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.623
SG - Singapore 7.174
RU - Federazione Russa 4.958
CN - Cina 4.898
IT - Italia 4.885
BR - Brasile 3.482
VN - Vietnam 2.594
GB - Regno Unito 1.787
HK - Hong Kong 1.432
BD - Bangladesh 1.391
DE - Germania 1.122
CA - Canada 1.005
FR - Francia 662
FI - Finlandia 537
SE - Svezia 504
IN - India 480
UA - Ucraina 472
IE - Irlanda 456
AR - Argentina 354
MX - Messico 335
NL - Olanda 291
TR - Turchia 291
PL - Polonia 253
ID - Indonesia 231
ES - Italia 198
ZA - Sudafrica 195
EC - Ecuador 184
IQ - Iraq 182
JP - Giappone 173
IL - Israele 171
PK - Pakistan 156
CO - Colombia 123
AT - Austria 108
VE - Venezuela 98
MA - Marocco 86
AE - Emirati Arabi Uniti 82
UZ - Uzbekistan 76
DK - Danimarca 72
LT - Lituania 66
PY - Paraguay 63
CL - Cile 61
EG - Egitto 58
MY - Malesia 56
SA - Arabia Saudita 56
PE - Perù 46
TN - Tunisia 46
CR - Costa Rica 44
KE - Kenya 44
CH - Svizzera 43
PH - Filippine 40
BE - Belgio 37
AU - Australia 32
UY - Uruguay 32
JO - Giordania 31
AZ - Azerbaigian 30
BO - Bolivia 30
JM - Giamaica 30
DZ - Algeria 29
HN - Honduras 25
RO - Romania 25
GT - Guatemala 24
CZ - Repubblica Ceca 23
NP - Nepal 23
KZ - Kazakistan 22
DO - Repubblica Dominicana 21
TH - Thailandia 21
OM - Oman 19
PT - Portogallo 19
EU - Europa 17
IR - Iran 17
AL - Albania 16
SK - Slovacchia (Repubblica Slovacca) 16
TT - Trinidad e Tobago 16
TW - Taiwan 16
KR - Corea 15
LB - Libano 15
NI - Nicaragua 15
SV - El Salvador 15
PA - Panama 14
ET - Etiopia 13
GR - Grecia 13
AM - Armenia 12
BG - Bulgaria 12
KG - Kirghizistan 12
NZ - Nuova Zelanda 11
PS - Palestinian Territory 11
BB - Barbados 10
GE - Georgia 10
HU - Ungheria 10
RS - Serbia 10
CI - Costa d'Avorio 9
HR - Croazia 9
LV - Lettonia 9
MD - Moldavia 9
SN - Senegal 9
BH - Bahrain 8
BY - Bielorussia 8
GY - Guiana 8
MC - Monaco 8
NO - Norvegia 8
Totale 74.598
Salva come PNG Salva come JPEG
Città #
Dallas 6.257
Singapore 3.737
San Jose 2.446
Ashburn 2.443
Beijing 1.791
Chicago 1.478
Los Angeles 1.424
Hong Kong 1.341
Council Bluffs 1.006
Moscow 918
Ho Chi Minh City 844
Milan 818
New York 686
Salt Lake City 613
Chandler 562
Southend 543
Rome 542
Buffalo 538
Santa Clara 511
Hanoi 508
The Dalles 474
Fairfield 462
San Mateo 451
Dublin 446
Houston 417
São Paulo 369
Wilmington 363
Lauterbourg 360
Woodbridge 360
Hefei 354
Tampa 351
Helsinki 334
Seattle 324
Cambridge 322
Elk Grove Village 276
Boardman 266
North Bergen 245
Portsmouth 243
Falls Church 237
Munich 235
Pisa 229
Phoenix 226
Orem 218
Warsaw 217
Stevenage 215
Ann Arbor 212
Montreal 212
Ottawa 211
Florence 207
Beauharnois 193
Jacksonville 191
Brooklyn 177
Mexico City 169
London 164
Frankfurt am Main 163
Dearborn 156
Lawrence 155
Toronto 154
Istanbul 152
Tel Aviv 148
Tokyo 147
Denver 146
Sterling 133
Atlanta 131
Stockholm 130
Lancaster 129
Poplar 128
Chennai 126
Johannesburg 124
Amsterdam 123
Miami 121
Nuremberg 119
Rio de Janeiro 119
Dong Ket 117
Lappeenranta 107
Da Nang 106
Naples 106
Columbus 105
Figino 105
Bologna 104
Haiphong 99
Boston 96
Turin 88
Belo Horizonte 86
Dulles 79
Manchester 73
Palermo 73
San Diego 73
San Francisco 71
Biên Hòa 70
Turku 70
Washington 69
Genoa 67
Tashkent 66
Quito 65
Ankara 64
Charlotte 64
Detroit 64
Mumbai 64
Brasília 61
Totale 43.552
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.851
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.710
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.585
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 899
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 742
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 625
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 493
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 467
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 458
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 453
Echocardiographic and Cardiac Magnetic Resonance Imaging-Derived Strains in Relation to Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy 444
A simple echocardiographic score to rule out cardiac amyloidosis 395
A simple echocardiographic score to rule out cardiac amyloidosis 376
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 370
Building medical knowledge from real world registries: The case of heart failure 366
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 362
Position paper ANMCO: Impiego di vericiguat nello scompenso cardiaco: dalle evidenze al posizionamento terapeutico 352
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 342
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 336
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 336
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 335
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 335
Treating chemoreflex in heart failure: modulation or demolition? 329
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 321
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 321
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 318
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 311
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 309
Eligibility for vericiguat in a real‐world, contemporary heart failure population 309
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 306
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 304
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 304
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 303
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 301
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 301
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 301
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 299
[Ten perspectives for research and innovation in cardiac amyloidosis] 299
Screening the health status of people working in a university 297
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 297
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 297
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 294
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 294
How to take arms against central apneas in heart failure 291
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 289
Sex-related differences in chronic heart failure 285
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 281
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 281
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 279
RNA-targeting and gene editing therapies for transthyretin amyloidosis 278
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 278
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 277
Unmet needs in end-of-life care for heart failure patients 274
Cardiac light-chain deposition disease relapsing in the transplanted heart 274
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 269
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 269
Atrial amyloidosis: mechanisms and clinical manifestations 268
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 268
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 267
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 265
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 264
Valve disease in cardiac amyloidosis: an echocardiographic score 262
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 262
Disease features and management of cardiomyopathies in women 261
Biomarkers for the diagnosis and management of heart failure: New frontiers 261
null 258
null 258
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 257
Biomarkers for the diagnosis and management of heart failure 254
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 254
null 253
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 252
Assessing cardiac mechanics through left ventricular haemodynamic forces 250
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 250
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 249
Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms? 249
Cardiac magnetic resonance in patients with muscular dystrophies 249
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure 248
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 247
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 244
Factors for heterogeneous outcomes of angina and myocardial ischemia without obstructive coronary atherosclerosis 244
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 243
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 243
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 243
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 242
Role of Imaging in Cardiomyopathies 242
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 241
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 240
Valvular heart disease in patients with cardiac amyloidosis 240
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 240
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 238
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 237
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 235
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 234
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 234
Cardiac troponins as biomarkers for cardiac disease 233
Perspectives in noninvasive imaging for chronic coronary syndromes 232
Cardiovascular disease and COVID-19: les liaisons dangereuses 232
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 230
Current and emerging treatment options for transthyretin amyloid cardiomyopathy 229
Totale 34.574
Salva come PNG Salva come JPEG
Categoria #
all - tutte 376.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 376.646
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.066 0 0 65 231 108 145 298 491 203 285 52 188
2022/20231.732 162 165 75 154 210 208 42 155 341 43 121 56
2023/20241.762 107 49 336 122 75 154 106 71 88 96 95 463
2024/202519.303 220 243 878 362 665 803 1.951 3.264 1.352 2.531 4.186 2.848
2025/202642.499 2.194 6.182 4.866 5.533 4.011 2.661 4.125 1.997 2.695 2.804 2.770 2.661
2026/20272.982 1.276 1.420 286 0 0 0 0 0 0 0 0 0
Totale 75.249